Kenvue in the news
Consumer health products manufacturing
Tamtam found 9 recent articles about Kenvue.
- Kimberly-Clark meeting with Brazil CADE signals attention to Kenvue review
Kimberly-Clark's meeting with Brazil's CADE signifies attention to Kenvue's regulatory review.
- Kenvue Inc. stock rises Thursday, outperforms market
Kenvue Inc. stock increased on Thursday, outperforming market trends but remaining below its 52-week high.
- Market Concentration Is Spooking Wall Street—I’m Buying Kenvue
Kenvue, a consumer health product manufacturer, is being acquired by Kimberly-Clark in a $48.7 billion deal, showing strong organic growth, substantial free cash flow, and an attractive dividend yield.
- Market Concentration Is Spooking Wall Street—I’m Buying Kenvue
An investor is buying Kenvue shares, citing its strong brands, high dividend yield, and ongoing acquisition by Kimberly-Clark, despite some market concerns.
- Kimberly-Clark’s (KMB) Kenvue (KVUE) Deal Has Jim Cramer Looking Years Ahead
Kimberly-Clark's acquisition of Kenvue is expected to generate significant synergies, despite both companies currently facing operational and margin pressures.
- A performance award vested at 100%; Kenvue (KVUE) executive received 36,597 shares.
Kenvue executive Carlton Lawson received 36,597 shares of common stock on October 2, 2026, at a price of $17.20 per share, after performance criteria were met.
- Neutrogena®, Aveeno®, and Regaine® Present New Scientific Evidence Demonstrating How Science-Backed Ingredients Support Healthy Skin and Hair
Neutrogena®, Aveeno®, and Regaine® presented new scientific evidence at the EADV Congress showcasing the benefits of ingredients like niacinamide, trehalose, colloidal oat, and minoxidil for healthy skin and hair.
- Kenvue (KVUE), Why Is It Drawing Fresh Attention Now?
Kenvue is experiencing leadership changes and stock price pressure amidst an acquisition, with its valuation considered undervalued despite potential litigation risks.
- Kimberly-Clark advances Kenvue acquisition with debt swap and EU remedies
Kimberly-Clark is advancing its Kenvue acquisition through a debt swap for up to US$7 billion and by offering concessions to address EU antitrust concerns, with some brand divestitures already agreed upon in other regions.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Kenvue?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies